Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives

• Ngā kaituhi matua: Igor Valentim Barreto (Author), Caio Bezerra Machado (Author), Davi Benevides Almeida (Author), Flávia Melo Cunha de Pinho Pessoa (Author), Renan Brito Gadelha (Author), Laudreísa da Costa Pantoja (Author), Deivide de Sousa Oliveira (Author), Rodrigo Monteiro Ribeiro (Author), Germison Silva Lopes (Author), Manoel Odorico de Moraes Filho (Author), Maria Elisabete Amaral de Moraes (Author), André Salim Khayat (Author), Edivaldo Herculano Correa de Oliveira (Author), Caroline Aquino Moreira-Nunes (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which end up synthesizing antibodies or antibody fragments, called M proteins, in excess. The accumulation of this production, both...